What is Aitrics?
Aitrics operates at the intersection of healthcare technology and predictive analytics, specializing in the development of sophisticated AI-driven solutions for clinical environments. The company's flagship product, AITRICS-VC, serves as a cornerstone of its value proposition, utilizing real-time electronic medical record (EMR) data to forecast patient deterioration with high precision. By providing medical professionals with reliable, data-backed decision support, Aitrics aims to optimize hospital workflows and improve patient outcomes. The firm has established a robust market position, distinguished by its commitment to AI reliability and quality, which has garnered significant industry recognition and validation from clinical stakeholders.
How much funding has Aitrics raised?
Aitrics has raised a total of $20.1M across 1 funding round:
Series B
$20.1M
Series B (2024): $20.1M with participation from Premier Partners, BSK Investment, DS Investment & Securities, and Bonum Investment
Key Investors in Aitrics
Premier Partners
Premier Partners is a venture capital firm that focuses on identifying and scaling high-growth technology companies, providing the necessary capital and strategic guidance to navigate complex market landscapes.
BSK Investment
BSK Investment is a specialized venture capital and private equity firm that targets early-to-growth stage enterprises, leveraging its financial expertise to foster innovation within the technology sector.
DS Investment & Securities
DS Investment & Securities is a financial institution providing strategic investment support and capital market services to emerging companies, with a focus on long-term value creation.
What's next for Aitrics?
With the infusion of this major enterprise-level funding, Aitrics is poised to scale its operational footprint and deepen its research and development capabilities. The strategic roadmap likely involves expanding the deployment of its predictive analytics platform across broader hospital networks and enhancing the interoperability of its AI models with existing health information systems. As the healthcare sector continues to prioritize digital transformation and proactive patient management, Aitrics is strategically aligned to capture significant market share. The company will likely focus on strengthening its clinical evidence base and pursuing further regulatory milestones to solidify its role as a leader in the healthcare AI ecosystem, ensuring that its technological advancements translate into tangible improvements in life-saving medical interventions.
See full Aitrics company page
